Anti-Inflammatory Activities Of An Herbal Formula Ky079

Wei Chen,Yan Zhang,Ningzhi Tan,Chunsheng Zhao,Jihe Yang,Jihong Lu,Jianhua Yin,Weiti Yin,Jia-Shi Zhu

DOI: https://doi.org/10.1096/fasebj.20.4.a604

2006-01-01

Abstract:Inhibition of cyclooxygenases (COX) is a common anti-inflammatory therapy. However, the clinical usage of COX inhibitors is limited by their adverse effects: GI adverse effects for selective COX1 inhibitors and severe cardiovascular and renal side effects for selective COX2 inhibitors. In this study, we evaluated the anti-inflammatory effects of a KY079 herbal formula, having balanced inhibitory effects against COX1 and COX2, in vitro and in vivo. KY079 was examined for its COX1 and COX2 IC50s, using COX inhibitor EIA kit. We found that IC50 of KY079 was 43 ug/mL for COX1 and 93 ug/mL for COX2. A swollen mouse ear model was used for in vivo anti-inflammatory screening. ICR mice were randomly assigned to 6 groups (n=10): KY079, positive drug, and vehicle control groups. KY079 was given to mice at 10, 20, 40 & 80 mg/kg for 3 days by gavage. Mouse ear swelling index was reduced significantly by 30% with Aspirin at 200 mg/kg (p=0.047). KY079 reduced the swelling index by 47%, 47% and 35% at doses of 20, 40 & 80 mg/kg (p=0.020, 0.008 and 0.048, respectively), but not with 10 mg/kg of KY079. We conclude that the herbal formula KY079 demonstrates COX1 and COX2 inhibitory effects in vitro, and anti-inflammatory effects at 20 mg/kg and higher in the swollen mouse ear model. Further studies will help determine efficacy of KY079 in adjuvant arthritis models and in humans.